Modular Medical Launches PivotPump.com After FDA Clearance, Initial Patients in June
MODD•Modular Medical launched PivotPump.com to support patients with its FDA-cleared Pivot tubeless insulin patch pump ahead of initial June 2026 user rollouts. The site offers educational content on pump therapy as the company targets a fall 2026 commercial launch following its April FDA clearance.
1. PivotPump.com Launch
Modular Medical introduced PivotPump.com on June 4, 2026, creating a dedicated portal for patients considering its tubeless insulin patch pump. The website includes simplified onboarding guides, FAQs, and interactive tools to help users evaluate the Pivot system’s suitability for daily insulin delivery.
2. April 2026 FDA Clearance
In April 2026, the FDA granted clearance for the Pivot insulin delivery system, marking a crucial regulatory milestone for Modular Medical. This clearance validates the device’s safety and usability and paves the way for patient access under real-world conditions.
3. June Patient Rollout and Fall Launch
The company expects its first cohort of patients to begin using Pivot therapy by June 30, 2026, as part of initial field testing. Modular Medical remains on schedule for a full commercial launch in fall 2026, aiming to expand distribution nationally.
4. Accessibility and Market Strategy
Pivot is designed to lower barriers for individuals facing cost and complexity issues with traditional pumps, emphasizing simplicity and clinician access to clinical data. Modular Medical’s strategy focuses on broadening adoption beyond power users by offering intuitive design and affordable insulin delivery.
